The BSE Sensex rose by 239.37 points (0.31%), closing at 77,578.38, while the NSE Nifty50 gained 64.7 points (0.28%), finishing at 23,518.50. This mild recovery offered some relief to investors who had been watching the indices dip over the past week.
The broader market reflected the positivity seen in the main indices, with the Nifty Smallcap100 and Nifty Midcap100 rising by 0.97% and 0.93%, respectively.
Impact on the stock market
Sectoral indices also showed green shoots, although Nifty Metal, PSU Banks, and OMCs ended slightly down for the day. Among the top performers, the Nifty Media Index led with an impressive 2.45% rise, followed by Nifty Auto, Pharma, Realty, and Consumer Durables, each gaining over 1%. The Nifty IT Index also rose modestly by 0.83%, suggesting a balanced recovery across different sectors.
You may also like: Avoid These Money Mistakes Before You Retire
| Sector/Index | Performance |
| IT & BPM sector | 0.83% |
| Healthcare sector | 0.88% |
| Oil & Gas sector | -0.32% |
| Real estate sector | 1.48% |
| PSU Bank in India | -0.62% |
Top gainers today
| Company | Price | Change % |
| M&M Share Price | 2,948.95 | 3.58 |
| Tech Mahindra Share Price | 1,699.65 | 2.34 |
| HDFC Bank Share Price | 1,742.25 | 2.18 |
| Trent Share Price | 6,423.85 | 1.94 |
| Eicher Motors Share Price | 4,965.45 | 1.84 |
Top losers today
| Company | Price | Change % |
| SBI Life Insura Share Price | 1,522.90 | -2.54 |
| Hindalco Share Price | 640.00 | -1.70 |
| Reliance Share Price | 1,241.65 | -1.51 |
| TATA Cons. Prod Share Price | 917.15 | -1.46 |
| HDFC Life Share Price | 680.40 | -1.46 |
Market aftermath: Impact on stocks
Shilpa Medicare Rises on Positive Drug Approval News
Shilpa Medicare emerged as one of the day’s top performers, driven by significant regulatory approvals. The stock rose over 6% in early trade, following the announcement that its subsidiary, Shilpa Pharma Lifesciences, had received two Certificates of Suitability (CEP) from the European Directorate for the Quality of Medicines & Healthcare (EDQM). These approvals, granted on November 18 and November 19, covered the synthetic peptide Octreotide and the calcium-channel blocker Nifedipine, both significant products in Shilpa’s pharmaceutical pipeline.
Shilpa Medicare’s shares traded 3% higher at ₹892, reinforcing its robust year-to-date performance. The stock has surged by an impressive 180% in 2024, outpacing the Nifty 50’s 9% gain over the same period. The strong performance and approvals could signal promising growth for Shilpa’s market share in the pharmaceutical industry.
Indian Hotels on Track with ‘Accelerate 2030’ Vision
Indian Hotels Company Ltd (IHCL) saw its shares climb 3% as the company unveiled its “Accelerate 2030” growth strategy. Under this ambitious plan, IHCL aims to expand its hotel portfolio to over 700 properties by 2030, doubling its revenue and ensuring a 20% return on capital employed. The company reported that it had already surpassed its initial guidance, achieving a portfolio of 350 hotels and posting record-breaking financial performance over ten consecutive quarters.
Puneet Chhatwal, IHCL’s Managing Director and CEO, expressed confidence in the company’s growth trajectory, citing favourable market conditions such as India’s forecasted 6.5% GDP growth and an increase in hotel demand. The company’s strategic focus on traditional business and innovative revenue sources highlights a blend of stability and adaptability in an evolving hospitality market.
You may also read: Indian Hotels Company Ltd
Havells India Invests in New Refrigerator Facility
Consumer electronics firm Havells India also experienced gains, with its share price rising nearly 3% following an announcement of a major manufacturing expansion. Havells is set to invest approximately ₹480 crore in a new refrigerator manufacturing facility in Ghiloth, Rajasthan, adding a capacity of 14 lakh units by Q2FY27. This development is significant as the company had previously outsourced refrigerator manufacturing; by moving production in-house, Havells expects to gain operational control and potentially improve profit margins.
The new facility aligns with Havells’ broader growth ambitions, and the market responded favourably, pushing the stock to an intraday high of ₹1,663.95 on the NSE. This strategic shift could bolster Havells’ position in the consumer appliances sector, especially as demand for quality and domestic manufacturing rises in India.
Also Read: Titans of Indian hospitality: A deep dive into Indian Hotels and EIH Ltd
Crude Oil Rises Amid Supply Disruptions
In the commodities market, crude oil futures saw an uptick due to production halts in Norway and Kazakhstan. November crude oil futures were trading at ₹5,845 on MCX, up 0.45% from the previous close, while December futures also moved up by 0.55% to ₹5,868. On the international front, Brent oil futures rose to $73.46, and WTI crude oil futures climbed to $69.31.
The disruptions were driven by a power outage at Norway’s Johan Sverdrup oilfield, a key production site in Western Europe, and ongoing repair works at Kazakhstan’s Tengiz oilfield, which cut output by up to 30%. Although both fields are expected to resume normal operations soon, the temporary reduction added upward pressure on oil prices.
Warren Patterson, Head of Commodities Strategy at ING Think, noted that while the global oil market is expected to remain in surplus through 2025, these incidents—along with geopolitical tensions between Russia and Ukraine—highlight the fragile balance in supply and demand that could cause price swings in the near future.
Conclusion
In summary, today’s Indian stock market showed a measured recovery, ending a week-long losing streak, with gains in major indices Sensex and Nifty supported by strong performances across various sectors. Key developments, including regulatory approvals for Shilpa Medicare, IHCL’s growth strategy, and Havells’ manufacturing expansion, contributed to notable stock movements. Additionally, crude oil prices responded to production hiccups in key international fields, adding to the day’s market dynamics.
As markets digest these sectoral and stock-specific updates, investors may find renewed interest in industries like pharmaceuticals, hospitality, and consumer electronics, each poised to capitalise on growth opportunities driven by both domestic and global factors.
For more stock market insights, check out the StockGro blog.
